drugset / Trial / NCT01878201
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Phase 2
Completed
75 enrolled
Boryung Pharmaceutical Co., Ltd
Asan Medical Center · collabChonnam National University Hospital · collabInje University · collabKyungpook National University Hospital · collabSeoul National University Bundang Hospital · collabSeoul National University Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to Evaluate the Antihypertensive efficacy of Fimasartan 30 mg during 24 hours in Patients with Mild to Moderate Essential Hypertension
Timeline
- Start
- 2013-05
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fimasartan | Small molecule | 30 mg | Oral |
| Comparator | Valsartan | Small molecule | 80 mg | Oral |